WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer ; day:06 ; month:07 ; year:2021 ; extent:3
Advanced science ; (06.07.2021) (gesamt 3)
- Urheber
-
de Nonneville, Alexandre
Finetti, Pascal
Birnbaum, Daniel
Mamessier, Emilie
Bertucci, François
- DOI
-
10.1002/advs.202101030
- URN
-
urn:nbn:de:101:1-2021070615090296933530
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- de Nonneville, Alexandre
- Finetti, Pascal
- Birnbaum, Daniel
- Mamessier, Emilie
- Bertucci, François
Ähnliche Objekte (12)
Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer — A Cohort from China
Endocan as a prognostic biomarker of triple-negative breast cancer
Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Prognostic model based on tumor stemness genes for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer — A Cohort from China
Endocan as a prognostic biomarker of triple-negative breast cancer
Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Prognostic model based on tumor stemness genes for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer — A Cohort from China
Endocan as a prognostic biomarker of triple-negative breast cancer
Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Prognostic model based on tumor stemness genes for triple-negative breast cancer